Stock NRSN NEUROSENSE THERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders NeuroSense Therapeutics Ltd.

Equities

NRSN

IL0011809592

Delayed Nasdaq
Other stock markets
 11:36:52 17/05/2024 pm IST 		5-day change 1st Jan Change
1.21 USD -0.81% Intraday chart for NeuroSense Therapeutics Ltd. +2.55% +54.15%
14/05 NeuroSense Partners with PhaseV for ALS Treatment Trial -- Shares Up MT
07/05 NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing of Disease Progression in High-Risk ALS Patients CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Neurosense Therapeutics Ltd. Announces Executive Changes
CI
Yael German Resigns from the Board of Directors of Neurosense Therapeutics Ltd
CI
NeuroSense Therapeutics Ltd. Expands Board of Directors and Adds Chief Medical Officer to Leadership Team
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NRSN Stock
  4. News NeuroSense Therapeutics Ltd.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW